Nitric Oxide: A Review of Its Role in Retinal Function and Disease  by GOLDSTEIN, IRA M et al.
Pergamon
VisionRes., Vol. 36, No. 18, pp. 2979–2994,1996
Copyright01996 Elsevier ScienceLtd. All rights reserved
PII: SO042-6989(96)OO017-X Printed in Great Britain
0042-6989/96$15.00 + 0.00
Minireview
Nitric Oxide: A Review of Its Role in Retinal Function and Disease
IRA M. GOLDSTEIN,* PHILIPP OSTWALD,* STEVEN ROTH*~
Received 12 April 1995; infinalform25 August 1995
Nitric oxide synthase (NOS), the enzyme that catalyzes the formation of nitric oxide from L-
arginine, exists in three major isoforms, neuronal, endothelial, and immunologic. Neuronal and
endothelial isoforms are constitutively expressed, and require calcium for activation. Both of these
isoforms can be induced (i.e., new protein synthesis occurs) under appropriate conditions. The
immunologic isoform is not constitutively expressed, and requires induction usually by
immunologic activation; calcium is not necessary for its activation. Neuronal and immunologic
NOS have been detected in the retina. Neuronal NOS may be responsible for producing nitric oxide
in photoreceptors and bipolar cells. Nitric oxide stimulates guanylate cyclase of photoreceptor rod
cells and increases calcium channel currents. In the retina of cats, NOS inhibition impairs
phototransduction as assessed by the electroretinogram. Inducible nitric oxide synthase, found in
Muller cells and in retinal pigment epitheliums,may be involved in normal phagocytosis of the
retinal outer segment, in infectious and ischemic processes, and in the pathogenesis of diabetic
retinopathy. Nitric oxide contributes to basal tone in the retinal circulation. To date, findings are
conflicting with respect to its role in retinal autoregulation. During glucose and oxygen deprivation,
nitric oxide may increase blood flow and prevent platelet aggregation, but it may also mediate the
toxic effects of excitatory amino acid release. This reactive, short-lived gas is involved in diverse
processes within the retina, and its significance continues to be actively studied. Copyright 01996
Elsevier Science Ltd
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INTRODUCTION
Nitric oxide (NO), a gas with a half-life of a few seconds
(Snyder & Bredt, 1992), has diverse physiological
functions, the nature of which have been elucidated
primarily in the past 5 or 6 years. Three important
systemsin which NO acts as a messengermoleculeare in
white blood cells, where it mediates cytotoxiceffects; in
blood vessels, where it acts as endothelial-derived
relaxant factor (EDRF); and in the central nervous
system, where NO acts as a neurotransmitter (Bredt &
Snyder, 1992).Within the central nervous system,NO is
also involved in diverse processes such as neurotoxicity
(Dawson, 1994), microphage and neutrophil-mediated
cytotoxicity (Kuo & Schroeder, 1995),platelet aggrega-
tion (Stewart et al., 1994), blood flow (Faraci & Brian,
1994), synaptic transmission (Dawson & Snyder, 1994),
and long-term potentiation (Haley et al., 1992).
In the retina, nitric oxide synthase (NOS) is found in
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retinal neurons, pigment epitheliums(Bredt et al., 1990;
Goureau et al., 1993b), amacrine and ganglion cells
(Dawson et al., 1991a; Koistinaho et al., 1993;
Yamamoto et al., 1993b), nerve fibers in the outer and
inner plexiform layers, and in photoreceptor ellipsoids
(Yamamotoet al., 1993a).The opticnerve of normal rats
was devoid of NOS (Yamamoto et al., 1993a).
Evidence is now emerging that NO is a mediator of
physiological,and possiblypathological,processesin the
retina. The finding that NO modulatesvoltage-gated ion
channels in rod photoreceptorssuggests that NO may be
involved in photoreceptor light transduction and photo-
receptor synaptic output (Kurenny et al., 1994). Results
of both in w“troand in vivo studies in different animal
species suggest that NO is involved in the control of
retinalblood flowunderbasal conditions(Deussenet al.,
1993;Seligsohn& Bill, 1993;Toda et al., 1994;Wiencke
et al., 1994)and followingretinal ischemia (Goldsteinet
al., 1995;Veriac et al., 1993).Diabetic vascular damage
in the retina may be mediated in part by NO (Tiltonet al.,
1993) and the enhanced expression of NOS by retinal
glial cells and pigment epitheliums in response to
lipopolysaccharide,interferon, and tumor necrosis factor
indicates a role for NO in the development of, or
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protection from, infection in the retina (Goureau et al.,
1994a, b). Accordingly, we will review the sources and
synthesis of NO, and the evidence that it is involved in
various processes in the retina, both under normal
conditionsand in disease.
NITRIC OXIDE FORMATION
NO is generated from the terminal guanidinonitrogen
of L-arginineby NOS. Formation of NO consumes five
electrons and results in the formation of L-citndline.An
intermediate reaction product, l@-hydroxy-L-arginineis
produced, but the chemical steps involved in its
conversionto NO and citrullineare not known (Marietta,
1994).NOS is an unusualoxidativeenzymeas most other
enzymes consume one or two electrons for similar
functions. Cofactors involved in this reaction include
calmodulin,NADPH (nicotinamideadeninedinucleotide
phosphate), BH4 (5,6,7,8-tetrahydrobiopterin), flavin
(flavin adenine dinucleotide or flavin mononucleotide),
and heme (Dawson & Snyder, 1994; Morris & Billiar,
1994).The heme in NOS reacts with carbon monoxideto
form a species absorbingat 445 nm, indicatingthat NOS
is a cytochrome P-450 enzyme (Dawson & Snyder,
1994). The NO formed by NOS appears to interact with
this heme group; this negative feedback inhibition may
be a mechanism whereby NO inhibits its own formation
(Rengasamy & Johns, 1993).
NOS exists in three isoforms. Two of these (neuronal
and endothelial) are constitutive, and are designated
cNOS. The third form, immunologic NOS, designated
iNOS, requires inductionby immunologicalsignals.The
reader is referred to many of the excellent recent reviews
which explain in detail differences between these
isoforms (Billiar, 1995; Dawson & Snyder, 1994; Kuo
& Schroeder, 1995; Marietta, 1994; Morris & Billiar,
1994; Nathan & Xie, 1994a; Schmidt & Walter, 1994;
Stamler, 1994; Stewart et al., 1994). In brief, all NOS
enzymes share the cofactors and substrates mentioned
above (with the exception of Ca2+/calmodulinbinding
effects), and are inhibited by L-arginineanalogs. Genes
coding for cNOS and iNOS are located on different
human chromosomes (endothelialon 7, neuronal on 12,
and iNOS on 17). Binding of calmodulin and Ca2+are
major controlmechanismsfor cNOS but are not essential
for iNOS activation (Nathan & Xie, 1994a). cNOS-
mediated release of NO is shortlived(hours);followinga
lag phase of several hours, NO released by iNOS
activation release may continue for days. Larger
quantities of NO are produced by iNOS compared to
cNOS. iNOS enzymes are stimulated by cytokines,
including lipopolysaccharide, interferon, and tumor
necrosis factor. The primary switch for control of cNOS
is Ca2+,while iNOS is regulated at the level of its mRNA
(Nathan & Xie, 1994a, b). These distinctions between
cNOS and iNOS explain their varying roles in homeo-
stasis. cNOS enzymes are regulators of short-term
phenomena;iNOS is involvedin longer-lastingcytotoxic
and immunologicalfunctions (Nathan & Xie, 1994a,b).
Once formed, NO exists as a gas, is highly reactive
because of its unpaired electron, and is poorly soluble in
water. Its half-life in biological tissue varies from 10 to
60 sec but may be prolonged to 4 min in the absence of
tissue and in the presence of oxygen (Kiechle &
Malinski, 1993).
NO readily diffusesacross cell membranes and has no
known storagemechanism.Many vasodilatorsexert their
effects on vascular smooth muscle by activating
endothelial NOS, releasing NO (EDRF) to the vascular
smooth muscle (Schmidt & Walter, 1994). NO reacts
with ferrous iron in the heme prostheticgroup of soluble
guanylatecyclase. The resulting increase in cyclic GMP
relaxes vascular smooth muscle and inhibits platelet
adhesion and aggregation (Moncada & Higgs, 1993).
Nitric oxide synthase: Retinal localization and charac-
terization
NADPH diaphorase, a histochemicalenzymatic activ-
ity that reduces tetrazolium dyes in the presence of
NADPH, but not NAD, has been used as a marker for the
presence of NOS in the retina (Dawson et al., 1991a).
NADPH diaphorase staining is present throughout the
visual system, indicating the widespread presence of
NOS (Vincent& Hope, 1992).In rats and in mice, retinal
NOS is found predominantly in amacrine cells, in
displaced amacrine cells in the ganglion cell layer, in
othercells in the innernuclearlayer, and in nerve fibersin
the outer and inner plexiformlayers (Huang et al., 1993;
Yamamoto et al., 1993b). Ca2+/calmodulin-dependent
NOS activity was induced in retinal ganglion cells, in
axons in the retinal nerve fiber layer, and in the optic
nerve of rats by pterygopalatineparasympatheticdener-
vation (Yamamoto et al., 1993a). NOS has not been
found in the retinal nerve fiber layer or in optic nerve
axons. Human retinal tissues have been found to express
mRNA for both cNOS and iNOS (Park et al., 1994).The
discovery of NOS activity (both by diaphorase staining
and by Northernblot analysisusing a cDNA probe) in the
developing chick tectum in proximity to retinal axons
(Williamset al., 1994)suggeststhat NOS may also play a
role in retinal development. The isoforms of NOS
possibly involved in this synaptogenesis have not yet
been elucidated.
The presenceof cNOS activity in the photoreceptorsis
controversial. Although the studies using immunocyto-
chemical and NADPH diaphorasehistochemicalstaining
failed to localize NOS activity within photoreceptors,
other investigators have detected cNOS activity in
extracts of bovine photoreceptor outer segments. These
discrepanciesmay be due to differences in experimental
conditions, or insensitivity of NADPH diaphorase
staining. In one study, NOS activity of photoreceptors
was assayed indirectly,by measuring the rate of change
in absorption of oxyhemoglobin as it was oxidized to
methemoglobin by NO. These authors determined that
the enzyme was Ca2+- and calmodulin-dependent,
required NADPH, used L-arginineas substrate, and was
inhibited by L-arginineanalogs (Venturini et al., 1991).
These propertiesof the retinalenzyme are thoseexpected
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of a cNOS. Other investigatorsused anti-NOSantibodies,
and localized cNOS in ellipsoid regions of bovine inner,
but not outer, photoreceptorsegments.Solubleguanylate
cyclase, a target enzyme for NO, was localized in nearby
cell bodies of cone photoreceptor cells (Koch et al.,
1994).These findingssuggest,but do not prove, that NOS
may have a neuromodulatoryrole in visual transduction
(see below, ‘Nitric Oxide and Visual Transduction’).
Further studies are required to precisely localize and
characterize the function of NOS in photoreceptors.
iNOS activity has been found within cells of the retina
and, althoughnot yet examined there, is probablypresent
within macrophages and neutrophils residing in the
ocular circulation. At present, the control and function
of retinal iNOS are still incompletelydefined,and there is
controversyabout the role of various mediatorsof iNOS,
Cultured bovine retinal pigment epithelial (RPE) cells
produced NO upon treatmentwith interferon(IFN) in the
presence of lipopolysaccharide(LPS) and tumor necrosis
factor (TNF). Approximately 12 hr was required for
induction of NO production, and its synthesis continued
for 96 hr (Goureau et al., 1992).Mediationby cytokines,
slow onset and prolonged release of NO are consistent
with the propertiesof iNOS in other tissues.WhetherIFN
or IFN-inducing agents like LPS exert effects upon
retinal iNOS that are at the transcriptional or post-
transcriptional level is not yet known. Transcriptional
induction of iNOS by these cytokines has only been
shown so far in mouse macrophages (Nathan & Xie,
1994b),and perhaps retinal iNOS is controlledsimilarly.
RPE iNOS was inhibited by dexamethasone, cyclohex-
imide, and L-arginine analogs (Goureau et al., 1992).
Inhibition by dexamethasonemay be via a post-transla-
tional effect, as the iNOS promoter does not possess
steroid recognition sites (Nathan & Xie, 1994b).
The effects of cytokines on RPE iNOS activity are
complex. Fibroblast growth factor inhibits NOS in
cultured bovine RPE, while transforminggrowth factor
P (TGF-jl) enhances iNOS activity (Goureau et al.,
1993b). NO itself may have an anti-proliferativeeffect;
nitriteor citrullineproductionfromthe cellswas inversely
correlatedwith the levelof cellularproliferation(Goureau
et al., 1993b). Phagocytosisof retinal rod outer segments
(ROS) by bovine RPE cells was inhibitedboth by SIN-1,
which releases NO, and by endogenousNO released by
cytokine-stimulatedRPE cells. This effect was antago-
nized by NO scavengers (hemoglobin) or, L-arginine
analogs and was not dependentupon cGMP (Becquet et
al., 1994), as expected of an iNOS. Perhaps the
physiologicalrole of iNOS in the RPE is to contributeto
phagocytosisof the rod outer segmentsthroughreleaseof
NO; further studiesare necessaryto test this hypothesis.
Cultured human RPE cells also possess an iNOS, with
properties like those of the bovine RPE enzyme.
However,differentmediatorsregulateNOS in the human
cells, Human RPE cells requiredboth interleukin-1~and
IFN to produce NO, and LPS did not increase NO
production. TGF-fl strongly inhibited NO production
from human, but not bovine, RPE (Goureau, O. et al.,
1994).Perhapsthe differencein the effectsof regulatorsis
due to differingexpressionof receptorsubtypesin various
cells or from the same cells of different species. It is not
known at what level of NOS expressionTGF-/?exerts its
effectsin the retina. In murinemacrophages,TGF-flacted
at multiplelevels, inhibitingiNOS translation,destabiliz-
ing iNOS mRNA, and accelerating the degradation of
iNOS protein (Nathan & Xie, 1994b).The recent cloning
of thehumaniNOS genemay allowus to soonunderstand
these mechanismsmore fully (Billiar, 1995).
Production of NO by activated macrophages is an
important cytostatic/cytotoxic defense mechanism
against microorganisms. NO acts on a number of
important biochemical pathways in microbes, including
aconitaseof the tricarboxylicacid cycle, complexI and II
of electron transport, and glyceraldehyde-3-phosphate
dehydrogenase. All of the enzymes affected by NO
containcatalyticallyactivenon-hemeironbound to sulfur
atoms.NO formsFe-nitrosylcomplexes,which inactivate
these enzymes, leading to death of the cells (Kuo &
Schroeder, 1995). Inhibition of ribonucleotidereductase
(the rate-limiting enzyme of DNA synthesis), direct
chemical action upon DNA, and the formation of toxic
oxygen free radical species are additional known toxic
effects of NO upon microbes (Morris & Billiar, 1994).
iNOS expression may be beneficial (e.g., in the
presence of bacterial infection, where release of NO
could lead to killing of microbes), or may be harmful
(e.g., autoimmune disease, or septic shock). At present,
little is known about the role of iNOS expression in
retinal pathology.Of interest is the finding that an iNOS
inhibitor decreased endotoxin-induced uveitis in rats
(Tilton et al., 1994),providing the first evidence that NO
is involved in ocular inflammation. Also, TGF-fl
(detected in aqueous humor) inhibited uveitis. Accord-
ingly, it is interestingto speculate that TGF-/l and iNOS
interact in regulating ocular inflammation. Such an
interaction may have important clinical significance in
the pathophysiologyof various eye diseases.
RPE cells are not the only retinal cells in which iNOS
has been detected. iNOS activity was also found in
Miiller glial cells of the rat retina (Goureau, D. et al.,
1994); these cells produced nitrite within 12 hr of
exposure to the mediators IFN, TNF, and LPS. iNOS
mRNA isolated from Miiller cells was similar in size to
that of microphage iNOS. TGF-fl inhibited cytokine-
mediated NO production. Recently, NOS activity was
detected in cytomegalovirus-infectedglial cells, particu-
larly Miillercells, in patientswith AIDS (Dighieroet al.,
1994). This is further evidence that iNOS is an immune
modulator in the retina. However, it is not known if this
increased iNOS expression is a marker of infection or a
component of the pathophysiology of infection. Also,
whether iNOS confersprotectionor greater sensitivityto
viral infectionis not clear. It is knownthat NO suppresses
T lymphocyteproliferationand cytolysis.This may result
in increased sensitivity to viruses during chronic
inflammation(Schmidt & Walter, 1994).
NO is most likely involved in retinal blood flow
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regulation (see below). Accordingly,NOS immunoreac-
tive nerve fiberswere found in peripheralocular tissues,
particularlyin the choroidand aroundlimbalbloodvessels
(Yamamoto et al., 1993b).These findingsare consistent
with a role for NOS in ocular blood flow regulation,
although these studies have yielded controversialresults
(see below). Most human choroidal nerve fibers were
found to stain for NOS (Fliigelet al., 1994).These nerve
fibers are predominantly derived from the ipsilateral
pterygopalatine ganglion. The choroid is more heavily
innervatedwith NOS nerve fibersin the temporal+entral
region than in the foveal region, perhaps reflecting the
need for greater circulatorycontrolof that area (Fliigelet
al., 1994).Virtually all NOS immunoreactivepterygopa-
latine-derived nerve fibers also stained positively for
vasoactive intestinal polypeptide and many also co-
localized with neuropeptideY in some of the neuronsof
this ganglion. The nerve fibers probably serve as para-
sympatheticmediatorsof choroidalvasodilatation,exert-
ing their effects through productionof NO. The anterior
peripheral ocular circulation was much less heavily
innervated. NOS-containing nerve fibers in the ciliary
body were chieflyfound adjacentto the circulation,rarely
found in the iris, and were not present in the cornea. The
vascularendotheliumin thechoroid,limbus,irisand retina
were NOS-immunoreactive(Yamamotoet al., 1993b).
MEASUREMENTOF NITRIC OXIDE
CONCENTRATION
To study the biological role of NO in a particular
process requires measuring its concentration.Due to its
reactivityand brief half-life,measuringNO concentration
in animal models has posed a serious challenge to in-
vestigators.As a result, NO concentrationhas generally
been inferred indirectly,based on readilyobservedeffects
such as productionof citrullinefrom L-arginine,determi-
nation of nitrite concentration,increased cGMP concen-
tration, vasodilatation (Kiechle & Malinski, 1993;
Moncada & Higgs, 1993) or by studying the effects of
inhibitionof NOS. Of these methods,only the concentra-
tions of cGMP or of citrulline yield quantitative infor-
mation regardingthe amountof NO produced(Kiechle&
Malinski, 1993). Direct measurement of NO concentra-
tion would be far preferable to these approaches.NO can
be measured directly using spectroscopicor electroche-
mical means. These methods, and their advantages and
disadvantageshave been reviewed recently (Kiechle &
Malinski, 1993). Application of direct measurement of
NO concentration in vivo has recently been performed
using a NO-sensitive microelectrode positioned in the
cerebralcortex (Malinskiet al., 1993).This is an exciting
technology that could yield considerable information
abciutNO release in intact organs.
Perhaps the most common means used to assess the
involvement of NO in a process is the use of NO
synthesisinhibitors,such as the L-arginineanalogs,or of
molecules which may combine with and thereby
deactivateNO, such as hemoglobin.The most frequently
used NOS inhibitors are the L-arginine.analogsnitro-L-
.—
arginine methyl ester (L-NAME), N-monomethyl L-
arginine (L-NMA),and nitro-L-arginine(L-NA)(Nathan,
1992).The mechanismsby which these agents inactivate
the enzyme are not clear. Covalentbonding between the
inhibitorand NOS is one proposedmechanism(Dwyer et
al., 1991).In brain preparationsfrom rats treated with L-
NA or L-NMA, irreversible inhibition of NOS has been
observed. These animals had received high doses of
inhibitorfor at least 4-7 days (Dwyer et al., 1991).Klatt
et al. (1994) studied the binding of L-NAand L-NMAto
NOS purifiedfrom porcinebrain. NOS was inhibitedby 5
min pre-incubation with 10 pm concentration of either
inhibitor. Yet, activity was restored by dilution with L-
arginine after 1 min for L-NMA,and after 30 min for L-
NA. This suggested a faster dissociationof the L-NMA
complex than its L-NA counterpart. Although the
mechanism of this effect is not known, it appears that
access of L-NMA to NOS is impaired by its bulky and
polar methyl group.
Because of lack of selectivity, L-alginine analogs
cannot distinguishbetween iNOS and cNOS, or between
endothelial and neuronal NOS. In cell culture or in
isolated blood vessels, aminoguanidineprovided selec-
tive competitive inhibition of iNOS (Joly et al., 1994;
Misko et al., 1993). In mice, 7-nitroindazoleselectively
inhibited neuronal, but not endothelial NOS (Moore et
al., 1993). Use of these compounds in vivo may allow
investigators to evaluate the effects of specific NOS
isoform inhibition. However, little is known still about
the dose–responseeffects of these agents, and it is quite
possiblethat specificitymay be dose-dependentin in vivo
experiments.
A disadvantageof using L-arginineanalogsis that they
exert other significant effects, which may obscure the
physiological role of NO in a given experimental
paradigm. For example, in isolated strips of coronary
artery or colonic smoothmuscle of rabbits,L-NAMEand
other L-arginine analogs containing carboxy terminal
alkyl ester substitutions functioned as muscarinic
antagonists(Buxton et al., 1993). Carboxy groups in L-
NAME and L-NMA may bind iron atoms. Accordingly,
in vitro, thesecompoundsinhibitedthe reductionof ferric
cytochrome c by ferrous iron, fatty acid-oxygen-iron
complex transfer of electrons to cytochrome c, and the
reduction of ferric cytochrome c by epinephrine (Peter-
son et al., 1992).In experimentstesting the involvement
of NO duringoxygenand glucosedeprivation(ischemia),
L-arginineanalogs may further decrease normal aerobic
metabolism and inhibit post-ischemic recovery by
inhibitionof mitochondrialenergy production.However,
the physiological significance of the in vitro data is
questionablebecauseNOS inhibitorsdo not affect resting
cerebral glucose utilization or oxygen consumption
(Iadecola & Xu, 1994; Kozniewska et al., 1992;
McPhersonet al., 1994).
Finally, an undesirable effect that accompanies
systemic administration of L-arginine analogs is en-
dothelial NOS inhibition, resulting in an increase in
arterial blood pressure. This effect is apparentlydue .toa
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decrease in EDRF, which is responsible for the main-
tenance of normal vascular tone, although there is
evidencethat a central effect may increasebloodpressure
(Togashi et al., 1992). Specific iNOS inhibitors did not
alter arterialblood pressure (Miskoet al., 1993;Mooreet
al., 1993), and are clearly a better choice in experiments
in intact animals.
NITRIC OXIDEAND VISUALTRANSDUCTION
cGMP in visualprocessing
3’-5’cyclic guanosinemonophosphate(cGMP)is a key
intermediate in the visual transductioncascade. Produc-
tion of cGMP from GTP is catalyzed by guanylate
cyclase (GC), a target enzyme for the action of NO
(Waldman & Murad, 1987). In photoreceptor outer
segments, cGMP controls ionic fluxes across the plasma
membrane by opening a specialized species of ion
channels, the cGMP-gated, non-selective cation chan-
nels. Absorption of light by visual pigments in rods and
cones triggersa cascade of eventsthat eventuallyleads to
a change in ionic fluxesacross the plasma membraneand
a consequent change of membrane potential (Koch,
1992).cGMP-gatedconductance have been found in the
inner and outer segmentsof the photoreceptor(Watanabe
& Matthews, 1988). cGMP-gated channels are also
present in bipolar cells (Nawy & Jahr, 1991; Shiells &
Falk, 1990),horizontalcells (DeVries & Schwartz, 1988;
Miyachiet al., 1991)and in ganglioncells (Ahmad et al.,
1994),but their role and regulation in these cells are not
yet well understood.
Briefly summarized, phototransduction occurs in
several stages: (1) Light absorption changes the 11-cis
retinal within rhodopsin into the all-trans configuration.
(2) Activated rhodopsin(metarhodopsinII) activatesa G-
protein (transducing)that activates a cGMP phosphodies-
terase (PDE). (3) This leads to reduction of intracellular
cGMP concentration via PDE-mediated hydrolysis of
cGMP to 5’GMP. (4) cGMP-gated Na+ channels close
and the photoreceptor cell hyperpolarizes. (5) cGMP
concentration is restored through resynthesisby guany-
late cyclase (GC) (Gorczycaet al., 1994)and possiblyby
inactivation of the phosphodiesterase (Kawamura &
Murakami, 1991). It is believed that the reduction of
the intracellularCa2+concentrationmediates the restora-
tion of cGMP levels by a negative feedback loop (Koch,
1992; Lagnado & Baylor, 1992; Pugh& Lamb, 1993).
Guanylate cyclase, the enzyme that catalyzes forma-
tion of cGMP from GTP, exists in two isoforms:a soluble
and a particulateform. Both isoformshave been shown to
exist in the retina. Fourdifferentclassesof particulateGC
(pGC) have been identified: atrial natriuretic peptide
receptor type A and B, guanylyl cyclase C and retinal
cyclase. All have in common that they are membrane
bound and have, in addition to their intracellular GC
catalytic domain, a large extracellular domain with
receptor-like ligand binding activity. For a review see
Schmidt et al. (1993).
ParticulateGC is foundprimarily in rod photoreceptors
(Ahmad & Bamstable, 1993; Horio & Murad, 1991;
Waldman& Murad, 1987).Rod outer segment(ROS) GC
is tightly associated with the cytoskeleton (Hakki &
Sitaramayya, 1990). Particulate GC is a single polypep-
tide chain of 150 kDa containinga binding site for atrial
natriuretic factor (Lowe et al., 1989). In addition to
particulate GC, rods also contain a soluble GC, which is
found in the cytoplasm(Marguliset al., 1992).Using in
situ hybridization,soluble GC was found throughoutthe
rat retina, with the greatest quantitiespresent in the inner
nuclear layer; particulate GC predominated in the rod
photoreceptors. Actual enzyme activity, however, was
not determined in this study (Ahmad & Barnstable,
1993). Soluble GC is a heterodimer of 70 and 82 kDa
subunits;interactionof NO or oxygen free radicals with
heme groups of both subunits leads to activation of the
enzyme (Ignarro, 1990). Both subunits are required for
regulation of activation and basal enzyme activity
(Buechler et al., 1991).
Possible role of nitric oxide in photoreceptors
There are two possible functions of NO in photo-
receptors:modificationof light responsesin photorecep-
tors, and modulation of synaptic transmission from
photoreceptors to bipolar and horizontal cells. These
functions may be mediated by effects of NO on GC or
other target enzymes or proteins in the retina.
Recent studiesusing combined immunohistochemistry
and/orbiochemicalcharacterizationlocatedNOS activity
mainly in rod inner segments(Koch et al., 1994;Kurenny
et al., 1994;Yamamoto et al., 1993b).Location of NOS
activity in close proximity to the GC target enzyme
makes NO a likely, although still unproven, effecter
molecule in photoreceptors. High levels of cGMP are
known to exist in photoreceptors (Ferrendelli & Vries,
1983)and cGMP immunoreactivitywas increasedby the
NO donor sodium nitroprusside (Berkelmans et al.,
1989), indicating the existence of a NO-sensitiveGC in
photoreceptors.In isolated frog rods, decrease in cGMP
concentration led to a hyperpolarization of the dark
voltageand a prolongationof lightresponses,which were
not reversiblewith donationof GTP. Additional applica-
tion of the NO donor SNP normalized dark current and
light response, indicating that cGMP concentration was
increasedvia stimulationof a GC by NO (Schmidtet al.,
1992). A similar finding was observed when L-arginine
was co-applied with the NOS cofactor NADPH to
isolated frog rods (Tsuyama et al., 1993).These findings
suggest that NO may be able to increase cGMP
concentration in photoreceptor outer segments, thereby
increasingcGMP-gatedconductance and altering visual
transduction.However, these results in isolated inverte-
bratecellshave yet to be confirmedin vertebrateanimals.
Retinal GC, which is insensitiveto NO and represents
the major fraction of GC activity (Marguliset al., 1992),
is found in ROS and was shown to be involvedin cGMP
synthesisafter light response (Dizhoor et al,, 1994). So
far, retinal GC is thought to be activated by a soluble
activator that acts as a Ca2+sensor. But these experi-
mental results are controversialand suggest the possibi-
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FIGURE 1. Proposed mechanisms of action of NO in the photo-
receptor. Adapted with permission from Koch et al. (1994). In the
outer segments (OS), decreased Ca2+concentration following light
stimulation leads to activation of particulate GC (pGC).Activation of
pGC is mediated by calcium binding protein (CaBP). Production of
cGMP (which acts upon cationic channels) from GTP results in
recoveryof the photoresponse.In the inner segments,NOSis activated
at increased Ca2+concentration,via the action of calmodulirr(CaM).
The resulting NO which is produced could have multiple effects,
includingstimulationof solubleGC(sGC),andmodulationof synaptic
transmission from the photoreceptor.Diffusionof NO to nearby cells
may have effects upon bipolar cells (GC activation) or may control
hemi-gapjunction channels in horizontal cells. NO may diffuse into
outer segments to stimulate ADP-ribosylationof OS proteins.
lity that other factorsbeside Ca2+may in fact be involved
in the regulation of retinal GC (Coccia & Cote, 1994).
Isolated rod outer and inner segments were shown to
containan NO-sensitivesGC (Kochet al., 1994;Margulis
et al., 1992).However, this sGC only represents a small
fraction of the total GC activity (Marguliset al., 1992).
ParticulateGC was unresponsiveto nitroprusside,and
thus to NO (Horio & Murad, 1991). cGMP increases in
isolated rods in response to NO and nitroprusside
application may therefore be attributable to sGC
(Schmidt et al., 1992). However, in bovine retina
extracts,NOS was found only in outer segmentsattached
to parts of inner segments (band II of rhodopsin, i.e.,
ellipsoid),but not in pure outer segment extracts (band I
of rhodopsin); sGC was detected primarily in band II,
with very little activity in pure outer segments.Although
NO may activate GC of rods and induce depolarization,
such activity has yet to be demonstrated in conjunction
with endogenousNO production.Thus, NO involvement
in control of cGMP in outer segments remains spec-
ulative (Koch et al., 1994). Further, due to the Ca2+
dependence of cNOS, and the decrease in the photo-
receptor concentrationof Ca2+during the light response,
the degree of NOS activity in the photoreceptorcell is in
question.With the light response, Ca2+concentration in
the photoreceptormay decrease to 140 nM, which is in
the range of Ca2+ sensitivity for GC activity (Koch,
1992).Brain cNOS is approximately20% of its maximal
activityat a free Ca2+concentrationof 140nM (Knowles
et al., 1989). No data are available yet on the Ca2+
dependence of photoreceptor NOS. Possible effecter
responsescausedby NOS of photoreceptors,theorizedby
Koch (Koch et al., 1994), are summarized in Fig. 1.
In addition to its effects upon GC, NO effects in
photoreceptorsmay be mediated through other mechan-
isms. NO has been shown to increase adenosine dipho-
sphate (ADP) ribosylationof a variety of proteins (Bribe
& Lapetina, 1990;Zhang et al., 1994)such as transducing
and G-protein and other, yet unidentifiedproteins in the
ROS (Ehret-Hilberer et al., 1992; Pozdnyakov et al.,
1993). NO-mediated post-translational modification of
cellular proteins may be a mechanism that alters
activation and deactivation of enzymes in the visual
transductioncascade of the ROS.
NO maybe involvedin synaptictransmissionfrom the
photoreceptors. Recently, the effect of NO on rod
photoreceptor ion channels was investigated. In sala-
mander retina, NOS was detected in photoreceptor
ellipsoids and distal portions of bipolar and glial cells
in proximity to photoreceptorinner segments. The NO-
releasing compound SNC, when applied to isolated
salamanderphotoreceptors,increased both Ca2+channel
current, which is involved in mediating photoreceptor
synapticoutput, and a voltage-independentconductance,
involvedin generatingphotocurrentsin the outer segment
(Kurenny et al., 1994). Ca2+ currents, either voltage-
gated or cGMP-gated, have also been shown to initiate
exocytosis at cone synapses (Rieke & Schwartz, 1994).
Thus, the NO-dependent Ca2+ current may modulate
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output at photoreceptor synapses, thereby affecting
transmissionof the photoresponseto the bipolar cells.
POSSIBLE ROLE OF NITRIC OXIDE IN BIPOLAR,
AMACRINE,HORIZONTAL,AND GANGLIONCELLS
NO donors or NOS inhibitors modified electrical
coupling in horizontal cells (DeVries & Schwartz,
1988; Miyachi et al., 1991) and altered cGMP-gated
synaptic conductance in ganglion cells (Ahmad et al.,
1994).However, a distinctfunctionalrole of NO remains
to be demonstrated.Three possible functionsof NO will
be reviewed: (1) modificationof light responses in ON-
bipolarcells; (2) effectsupon electricalcouplingbetween
horizontal cells; and (3) alteration of electrical excit-
ability of ganglion cells.
Cone ON-bipolar cells transmit light responses of
cone-photoreceptors to ganglion cells. In the dark,
photoreceptorsrelease relatively high amounts of gluta-
mate into the synapticcleft,which bind to a metabotropic
glutamate receptor present in ON-bipolar cells (for
review see Barnstable, 1993).Activation of the receptor
is thought to activate a G-protein, which activates a
phosphodiesterase hydrolyzing cGMP (Nawy & Jahr,
1990, 1991;Shiells & Falk, 1990). Consequently,with a
decrease in cGMP-concentration, cGMP-gated cation
channels close and the ON-bipolar cell hyperpolarizes
(Nawy & Jahr, 1990, 1991; Shiells & Falk, 1990).
Followinglight stimulation,cones release less glutamate,
which leads to an increase in cGMP in ON-bipolar cells
and, after opening of cGMP-gated cation channels, to a
depolarizationof ON-bipolar cells (Nawy & Jahr, 1990,
1991; Shiells & Falk, 1990). Although there are many
similaritiesto the light response of photoreceptors,there
are also important differences. Bipolar cells, express a
different cGMP-gated channel than photoreceptors
(Shiells & Falk, 1992b; Wassle et al., 1992). The
guanylate cyclase responsible for cGMP production
differs between ROS and ON-bipolar cells. Retinal GC,
located in ROS, is assumed to be a particulate form
(Ahmad & Barnstable, 1993). The GC of ON-bipolar
cells is an NO-sensitive sGC (Ahmad & Barnstable,
1993; Shiells & Falk, 1992a). Accordingly, cGMP
immunoreactivityincreased in ON-cone bipolar cells of
rabbit retina after application of NO-donors (Koistinaho
et al., 1993).Amacrine cells, which are NADPH positive
and in closeproximityto ON-bipolarcells, are thereforea
possible source of NO to activate sGC in these cells
(Koistinahoet al., 1993).
Once NO has entered ON-bipolarcells it may not only
act upon sGC, but also initiateADP-ribosylation.In fact,
like transducingin photoreceptors,the G-protein coupled
to the glutamatereceptorsin ON-bipolarcells is sensitive
to ADP-ribosylation by pertussis- and cholera-toxin,
identifying the G-protein in ON-bipolar cells as a
possible target for NO-mediated ADP-ribosylation
(Shiells & Falk, 1992b).
In preliminary experiments in goldfish retina an NO-
donor decreased inter-bipolarcell junctions, whereas L-
NAME, a NOS inhibitor,enhancedthosejunctions(Sakai
& Ball, 1994). Therefore NO may also have an impact
upon shapeof the receptivefieldof bipolarcells.Another
way NO may alter synapticretinal transmissionis via an
interactionwith dopamine,which is thought to modulate
synaptic transmission from photoreceptors to OFF-
bipolar cells (Maguire & Werblin, 1994). NO has been
shown to decrease endogenousdopamine release in the
retina via a cGMP-independentmechanism (Bugnon et
al., 1994).Thus, NO may also be involvedin modulation
of synaptic transmissionto OFF-bipolarcells.
Extensive electrical coupling of horizontal cells via
gap junctions is found in the retina. Modulation of
electricalcouplingcan alter receptivefield sizes and thus
influence the lateral spread of light responses in the
retina. Application of cAMP, cGMP, L-arginine,or the
NO-donor SNP to horizontal cells decreased electrical-
and dye–tracer coupling between horizontal cells
(DeVries & Schwartz, 1988; Miyachi et al., 1991).
Dopamine similarly decreased electrical coupling in
horizontal cells (DeVries & Schwartz, 1988), and since
NO decreased dopaminerelease in the retina (Bugnonet
al., 1994), NO’s effect on electrical coupling of
horizontal cells may be mediated through dopamine.
The cellular source of NO producing the decoupling
effect could be either horizontalcells, photoreceptorsor
amacrine cells. Horizontal cells are an unlikely source,
since although NOS and NADPH diaphorase activity
have been found in horizontalcells of the goldfishretina,
such activity has not been demonstrated in higher
vertebrates (Yamamoto et al., 1993b).The existence of
NOS in photoreceptors and amacrine cells has been
shown as discussedearlier.
Ganglion cells are the output neurons of the retina.
Since NADPH diaphorase activity is present within the
ganglion cell layer, possibly from displaced amacrine
cells (Liepe et al., 1994; Yamamoto et al., 1993b), NO
may modulate ganglion cell activity. Expression of
mRNA coding for a soluble GC has been shown in the
ganglion cell layer of rats (Ahmad & Barnstable, 1993).
Recently, the existence of a cGMP-gated non-selective
cation channel, like that in photoreceptors, has been
demonstratedin ganglioncells (Ahmad et al., 1994).NO
donors and a PDE inhibitor increased cGMP-gated
conductance in ganglion cells, suggesting the presence
of a NO-driven cGMP system in ganglion cells (Ahmad
et al., 1994).Ahmad has proposed a theory of how NO
may act in ganglion cells (Fig. 2). Amacrine cells in the
ganglion cell layer synthesize NO that diffuses to
ganglion cells. There it activates a sGC leading to an
increase in cGMP concentrations.This in turn may alter
ganglion cell membrane potential and intracellular ion
concentrations(e.g., for Ca2+).Analogouslyto findingsin
ON-bipolar cells, the possible existence of a G-protein
coupled to a receptor activating or inactivating a PDE
which hydrolyzes cGMP was postulated. However, the
existenceof such a mechanism in ganglion cells has not
been shown. In conclusion,the role of NO in the control
of the ganglion cell response remains speculative.
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FIGURE 2. Proposed pathways regulating activity of the cGMP-gated channel of retinal ganglion cells. Adapted with
permission from Ahmad et al. (.1994). Proposed reactions are shown with a dotted line, while known reactions appear in solid
lines. G = G protein; R = G protein-coupled receptor; T = transmitter. Release of NO from amacrine cells stimulates GC of the
ganglion cell. cGMP produced from GC acts upon cation channels in the ganglion cell. cGMP is degraded by phosphodiesterase
(PDE). PDE activity is modulated by a G-protein, whose activity is modulated by a neurotransmitter released from bipolar cells
which binds to R.
Effects of nitric oxide synthase inhibition on the
electroretinogram
Recent studies in our laboratoryon the effects of NOS
inhibitionon the electroretinogram(ERG) in cats provide
the first evidence of NO involvementin visual transduc-
tion in intact vertebrate eyes (Ostwald et al., 1995). L-
NAME, 30 mgkg was given intravenouslyto adult cats,
and NOS activitywas decreased90-95?4 in the retinaand
choroid. The dark-adapted ERG response to single 10
psec white light flasheswas measured.Both the a- and b-
wave amplitudeswere decreased significantlycompared
to saline-injectedcats starting 1hr afterL-NAMEadmini-
stration,and 6 hr later, the a- andb-wave amplitudeswere
64% and 51% of pre-L-NAME baseline, respectively.
These effects on the ERG were completely reversed by
intravenous administrationof L-arginine(200 mg/kg/hr)
(Roth et al., 1995). Since the b-wave was affected more
profoundly than the a-wave, perhaps NOS is of greater
importance in inner retinal, rather than photoreceptor-
related events in the visual transduction pathway. This
speculationcould be answeredperhapsby performingre-
cordingsin the vicinityof specificcell populations,rather
than the whole retina ERG. These findingsalso suggest
the need for further studies, perhaps using microelec-
trodes to measure NO release or the effects of specific
NOS inhibitorson the visual transductionpathway.
NITRICOXIDEAND THE REGULATIONOF RETINAL
BLOOD FLOW
The cerebral and retinal vasculature share many
similarities.Sincerelativelymore informationis available
on the role of NO in the regulationof cerebralblood flow
(CBF) than of retinal blood flow, it is useful to briefly
review studieson the role of NO in the controIof cerebral
circulation. NO functions as a vasodilator in responseto
local stimuliwithin the cerebral circulation (Moncada&
Higgs, 1993). Furchgott & Zawadzki (1980) suggested
that NO was EDRF, responsiblefor mediatingthe effects
of acetylcholine on vascular smooth muscle. EDRF
produces vasodilatation when NO binds to the heme
component of soluble GC located in vascular smooth
muscle (Moncada& Higgs, 1993).Heme groups of both
subunitsof solubleGC must be bound by NO in order to
activate the enzyme,which occurs when nitrosylationby
NO displacesheme-ironout of the plane of the porphyrin
binding site (Bredt & Snyder, 1992; Ignarro, 1990).The
catalytic site of soluble GC is activated, resulting in
increases in cGMP and relaxation of smooth muscle
(Waldman & Murad, 1987). The same mechanism
operates to inhibitplatelet aggregation(Moncada, 1992).
The NO that producesvasodilatationthroughaction on
vascular smoothmusclemay be synthesizedat sitesother
than endothelium. Alternate sites of NO production
include NOS-containing perivascular nerve fibers and
astrocytesadjacentto cerebralbloodvessels (Bredt et al.,
1990;Iadecola et al., 1993;Murphy et al., 1991;Nozaki
et al., 1993).
Neuronal activity is an important factor in the
regulation of CBF. Thus, activation of the N-methyl-D-
aspartate(NMDA receptor,which is involvedin synaptic
transmission)of rabbit brain increased CBF, but isolated
cerebral arterioles did not vasodilate in response to
NMDA. In vivo, NMDA-induced vasodilatation was
attenuatedby NOS blockade, suggestingthat vasodilata-
tion was mediated by neuronal, rather than endothelial-
produced NO (Faraci & Breese, 1993). There are
conflicting data, however, on the effects of NOS
inhibition on the CBF response to focal or global brain
activation (Iadecola, 1993; Iadecola et al., 1994).
BASAL TONE IN THE RETINALAND CHOROIDAL
CIRCULATION
Several investigatorsexamined the role of nitric oxide
and the endothelium in mediating the tone of isolated
retinal or ophthalmic artery segments. In porcine
ophthalmic artery segments, L-NMAproduced endothe-
lium-dependentcontractionswhich were reversed by L-
but not by D-arginine.L-NMA attenuated acetylcholine-
induced relaxation in vessels with intact endothelium
(Yao et al., 1991). Relaxationof isolated retinal arteries
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in response to nicotine (Toda et al., 1994), substance P
(Kitamura et al., 1993), and histamine (Benedito et al.,
1991)appears to be mediated through the release of NO.
Relaxation of isolated posterior ciliary arteries from the
cow was decreased by NOS blockade and methylene
blue, but was not altered by removal of the endothelium,
suggesting that release of NO from perivascular nerves
was responsiblefor vasodilatation(Wienckeet al., 1994).
In support of this hypothesis, nerve bundles containing
NOS were detected in the adventitiaand media of the dog
retinal artery (Toda et al., 1994).Additional support for
the involvementof NO was found using cultured bovine
pericytes,which relaxed and producedcGMP in response
to the NO donor, sodium nitroprusside.Responseswere
blocked by methylene blue via inhibition of GC
(Haefliger et al., 1994). Further, relaxation of isolated
human ophthalmicarteriesby NO has been demonstrated
(Haefligeret al., 1992).Thus in vitro studiessuggestthat
retinal vascular tone may be regulatedby NO both under
basal conditions, as well as under pathological condi-
tions, when vascular mediators may be released or the
endotheliumis damaged.
Studies examining the effects of NOS inhibition on
ocular blood flow have yielded conflicting results. The
effect of L-NAME on regional ocular blood flow was
studied in anesthetized dogs. A dose of 20 mg/kg L-
NAME iv. resulted in significant increases in mean
arterial blood pressure, accompanied by 40-50?4 de-
creases in blood flowin the choroid, iris, and ciliarybody
without a significant change in retinal blood flow
(Deussen et al., 1993). Varying findings were reported
when 300 mg/kg L-NAMEwas administered to rabbits.
Blood flow decreased nearly 50% in all ocular tissues,
including the retina (Seligsohn & Bill, 1993).However,
in cats 30 mg/kg L-NAMEsignificantlydecreased blood
flow in the iris, but not in the retina or choroid. In this
study,L-NAME10mg/kgwas sufficientto decreaseNOS
activity by 90–95%in the retina and choroid (Ostwaldet
al., 1995).In the newborn pig, microsuffusionof L-NMA
over the retina resulted in arteriolar vasoconstriction
under basal conditions, but no alteration in the retinal
arteriolar response to hypoxia,hypotension,or hypercar-
bia (Gidday & Zhu, 1995).The findingsof these studies
may have differed owing to species and anesthetic
differences and may have been affected by, varying
degrees of NOS inhibition. In summary, it appears that
NO is a significant factor in the control of uveal
circulation and is probably involved in regulation of
retinal blood flow.
Physiological alterations in retinal and choroidal
circulation
Few data are currently availableon the involvementof
NO in mediating responses of the ocular circulation to
physiological alterations, such as systemic hypoxia,
hypercarbia, changes in perfusion pressure, or visual
stimuli. In a preliminary study; retinai Wmodilationin
response to hypoxia was not associated with release of
NO (Pommmas et & 1993). As in-t.he..cerebralcortex,
increased retinal blood flow in response to hypoxia was
attenuated by adenosine receptor blockade (Gidday &
Park, 1993). NOS blockade did not alter the retinal
vascular responseto hypoxiain newbornpigs (Gidday &
Zhu, 1995).
During normoxic hypercapnia, retinal vessels dilated
without an increase in NO release, and L-NA did not
attenuate vasodilatation(Donati et al., 1994). Similarly,
L-NMAdid not attenuatethe retinal vascular responseto
hypercarbia in newborn pigs (Gidday & Zhu, 1995).
Because NOS blockade may have been incomplete and
the measurement of NO may not have been sufficiently
sensitive in these investigations, further studies are
necessary to confirm or deny NO involvement in the
retinal vascular response to hypercapnia.
The retinal circulation autoregulates, and as a result,
bloodflowremainsrelativelyconstant,despitechangesin
perfusion pressure (Aim & Bill, 1987). ChemicaI
messengers are believed to mediate this response, and
the role of NO was examined in two preliminary studies
in piglets.Local retinal administrationof L-NMAdid not
alter the blood flow response to hypotension, and the
investigatorsconcluded that NO was not responsiblefor
autoregulation.However, retinal NOS activity was not
measured, so it is possible that the results were due to
inadequateNOS blockade (Gidday & Zhu, 1995). In the
second study, systemic administration of L-NAME
reduced choroidal and retinal blood flow as perfusion
pressure in the eye decreased (Jacot et al., 1994). In a
recent report, neurally derived NO was shown to be
largely responsiblefor choroidalblood flow increases in
responseto stimulationof the Edinger–Westphalnucleus
in pigeons(Zagvazdinet al., 1996).Further investigation
is needed to clarify the role of NO in autoregulationin the
retina.
Increased retinal blood flow in response to flickering
white light flasheswas inhibitedin the presence of L-NA
in a preliminarystudy,suggestinga role for NO in linking
blood flow and visual transduction(Kondo et al., 1994).
Post-ischemichyperemia
After 60 min of ocular ischemia in cats induced by
elevation of intraocular pressure, retinal blood flow
measured with radioactive microsphere increased by
over 300%,5 min after ischemiaended (Roth & Pietrzyk,
1994).Choroidalflowwas significantlyhyperperfusedas
well. Blood flow was near pre-ischemic baseline 1 hr
after ischemia ended. Although the relationshipbetween
these blood flow changes and visual outcome has not yet
been established,post-ischemichyperemia of the retinal
circulationwas partiallyattenuatedby adenosinereceptor
blockade (Roth, 1995). Prior NOS inhibition using L-
NAME eliminated the effect of adenosine receptor
blockade (Roth et al., 1995). A possible explanation is
that NOS blockade diminished pre-junctional NO
attenuation of adenosine release, overcoming the effect
of adenosine receptor blockade. Consistent with this
hypothesis is the finding that, in the presence of NOS
inhibition, adenosine release accompanying reactive
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hyperemia in the guinea pig heart was enhanced (Kostic
& Schrader, 1992).However, other mechanisms,such as
NO effects upon cAMP release or NO and 02 free
radical-inducedactivationof 5’-nucleotidasemay also be
involved (Kitakaze et al., 1993). NO appears to play a
complex role in the blood flow changes that occur after
retinal ischemia, but further work is necessary to clarify
its involvementin the complexbiochemicalchanges that
accompany ischemia.
NITRIC OXIDEAND ISCHEMICDISEASEIN THE
RETINA
Retinal ischemia occurs as a result of primary ocular
disease, such as retinal vascular occlusion or as a
consequence of systemic disease, such as diabetes
mellitus. Excitatory amino acids (glutamate and aspar-
tate) are involved in the initiation of ischemic damage
(Zeevalk & Nicklas, 1990). Subsequently, increases in
intracellular calcium and in oxygen free radical activity
are believed to produceultimatecell death by destruction
of crucial cellular elements such as DNA, proteins, and
the cell membrane (Choi, 1990). NO may be significant
in this pathway because of its interactionwith excitatory
amino acid receptors; its role in free radical pathology;
and its effectsuponblood flow,neutrophilactivation,and
platelet aggregation.
Nitric oxide and glutamate neurotoxicity
Under normal conditions, glutamate and aspartate
released from nerve terminals are effectively taken up
from the extracellular space (Schousboe, 1981). When
released in excess or if re-uptake is ineffective, as may
occur in ischemia, the excitatory amino acids produce
neurotoxicity (Lipton & Rosenberg, 1994). Exposing
chick retina to NMDA results in acute cell swelling and
increased GABA release into the medium. If NMDA is
removed from the medium, the swelling is eliminated,
but delayed excitotoxicity occurs nonetheless, with
degeneration of the amacrine cells and neurons of the
ganglion layer (Zeevalk et al., 1989). Acute neuronal
injury results from swelling, induced by the opening of
membrane cation channels, leading to Na+ influx,
membrane depolarization,and osmotic influx of Cl- and
water (Choi, 1987). The more slowly evolving compo-
nent depends on an influx of Ca2+and resultant enzyme
activation (Choi, 1990). Neurotoxicity with excessive
Ca2+is more readily induced by low levels of glutamate
and thus may predominate under many pathological
conditions(Choi, 1987).
Experimentally induced ischemia in isolated rat and
rabbit retina stimulated a Ca2+-independentincrease in
glutamate and aspartate of 100% after 30 min ischemia
and a 15- to 20-fold increase after 90 min ischemia(Neal
et al., 1994). These findings are consistentwith in vivo
experiments in which glutamate receptor antagonists
decreased ischemic damage in the retina (Tsukahara et
al., 1992; Yoon & Marmor, 1989). Once released,
glutamate and aspartate bind to and stimulate NMDA
receptors, increasingintracellularCa2+concentrationand
stimulatingcNOS to produceNO (Bredt & Snyder, 1989;
Garthwaiteet al., 1988, 1989).
The NO produced after release of glutamate may be a
mediator of neurotoxicity.This hypothesiswas strongly
supportedby studies of NO toxicity in rat fetal cortical,
striatal, and hippocampalneurons (Dawsonet al., 1991b,
1993). Neurotoxicity produced by administration of
NMDA or sodium nitroprusside was similar in time
course and dose–responseeffect. Further, neurotoxicity
mediated by the calcium ionophore A23187 was No-
ndependent,as toxicity was attenuated by L-NA, hemo-
globin, and L-arginine-freemedium. Calmodulinantago-
nists blocked neurotoxicity, indicating that Ca2+
neurotoxicity involves calmodulin and probably calmo-
dulin-activated cNOS. Blockade of GC did not alter
neurotoxicity by NMDA and, therefore, cGMP is
probably not a mediator of toxicity. NOS expression in
culture over time was coincidentwith NMDA-mediated
cell death,and NOS was foundprimarily in processesand
cell bodies of neurons (less than 1–2% of the total
neuronalpopulationwas found to contain NOS). Several
mechanisms are postulated for NO toxicity: NO-related
damage to proteins,DNA, and membranephospholipids,
direct inactivationof mitochondrialenzymes,and energy
depletion following activation of poly ADP ribose
synthase after NO damage to DNA (Dawson, 1994).
NO stimulatesfurther release of excitatory amino acids,
thereby providing excitatory amino acid upregulation
duringischemia(Guevara-Guzmanet al., 1994;Imnartet
al., 1992). Preliminary studies indicate that NO also
mediates glutamate toxicity in cultured retinal neurons
(Kashii et al., 1994).
In contrast to these findings, delayed cell death after
exposure of embryonic chick retina to NMDA was not
attenuatedby L-NA (Zeevalk & Nicklas, 1994). In these
experiments,glutamate, NMDA, and kainate stimulated
two- to threefoldincreasesin cGMP,which were blocked
by L-NAor by hemoglobin.Administrationof L-arginine
partially reversed the L-NA-induceddecrease in cGMP.
The lack of effect of NOS inhibitionon delayedcell death
in the chick retina is probably due to predominance of
other mechanisms in this species over NOS activation.
Endothelial damage and inducible nitric oxide synthase
activationduring ischemia and reperjitsion
Restoration of the circulation after ischemia leads to
endothelialdysfunctionand the formation and activation
of a multitudeof humoralmediatorsof inflammationand
injury, includingoxygen-derivedfree radicals (hydrogen
peroxide, superoxide, and hydroxyl radicals), lipid
mediators (platelet activating factor and leukotrienes),
and polypeptidemediators(e.g., C5a). Endothelialinjury
with reduced NO, adenosine, and prostacyclinpromotes
inflammationand local injury through several mechan-
isms: vasoconstriction,platelet aggregation, and neutro-
phil adherence to the endothelium,all normally opposed
by these substances (Lefer & Lefer, 1993). Polypeptide
mediators provide a signal for microphage and neutro-
phil aggregationand adherenceto the endothelium.Over
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time (minutes to hours) these mediators promote
diapedesisof neutrophilsacross the endothelium(Lorant
et al., 1991). Pathologicalevidence of these phenomena
after retinal ischemia has been detected. Erythrocytes,
white blood cells, and fibrogranulardeposits have been
found scattered throughout the retina after ischemia,
usually localized to the inner layer (Anderson & Davis,
1975;Hughes, 1991;Johnson & Foulds, 1978;Shakib &
Ashton, 1966), along with trapped white blood cells
within retinal vessels (Wilson & Hatchell, 1991). In the
later stages of reperfusion injury, these activated white
blood cells could generate free radicals, which result in
further, delayed tissue destruction (Rowe et al., 1984;
Samuni et al., 1988).
Activated macrophagesand neutrophilscontain iNOS,
which can generate large quantities of NO for several
days, possibly another factor in delayed reperfusion
damage. The activation of iNOS during or immediately
after ischemia may stem from release of cytokines and
may result in further toxic free radical formation (Morris
& Billiar, 1994). Cytokine levels may rise as a result of
infiltration of macrophages or neutrophils into tissues
during reperfusion (Lees, 1993). Although free radical
toxicity is involved in retinal ischemic damage, it is not
currently known to what extent, if at all, iNOS activity
contributes.If iNOS activationis involved,possiblesites
for the origin of NO includewhite blood cells within the
retinal circulation, iNOS-containingMullerglial cells, or
the RPE. There is support for a theory that activated
neutrophilsproduce NO via iNOS, from studies of focal
or global cerebral ischemia.After occlusionof the middle
cerebral artery in spontaneouslyhypertensiverats, iNOS
mRNA was expressed starting at 12 hr, peaked at 48 hr,
and returned to baseline by 7 days. iNOS immuno-
reactivity was detected in neutrophilsin the infarct zone
at 48–96 hr after ischemia (Iadecola et al., 1995b). In
contrast, cNOS activity assayed in infarcted cerebral
cortex in the same modeI of ischemia was significantly
reduced at 1–7 days after ischemia (Iadecola et al.,
1995a). Seemingly contradicting these findings, iNOS
immunoreactivity was detected in astrocytes, not neu-
trophils, after transient global cerebral ischemia (Endoh
et al., 1994).This result may be due to differencesin the
pathophysiological mechanisms in these two different
modelsof ischemia.However, all of these studiessuggest
that activationof iNOS is a delayed event occurringlong
after the onset of cerebral ischemia, and perhaps
contributingto late cell death. Transgenic mice deficient
in iNOS and thereby resistant to cardiovascularcollapse
after injection of LPS have recently been developed
(MacMicking et al., 1995). Studies of ischemia in this
model may help to further elucidate the role of iNOS in
ischemic injury in the central nervous system.
It has been speculated that iNOS activity may be
responsible in part for diabetic vascular damage in the
retina, as well as in other tissues, through NO-induced
increases in blood flow and vascular permeability. In
diabeticrats, 1251-labeledalbuminentry acrosstheblood–
retinal barrier, an indicator of altered vascular permea-
bility, was decreased by chronic administration of
guanidine compounds. Guanidines inhibit iNOS, sug-
gesting that iNOS activity is increased in the diabetic
retina. However, guanidines also inhibit advanced
glycation end product (non-enzymatic glycation), be-
lieved also to be involvedin diabeticvascular complica-
tions (Tilton et al., 1993). Since effects other than NOS
inhibition may be mediated by these compounds,
definitiveproof that NO producesdiabeticretinaldamage
is lacking.
Interaction of free radicalsand nitric oxide
Catabolism of purines via the xanthine oxidase path-
way and metabolismof free fatty acids and arachadonic
acid lead to the production of oxygen free radicals
(hydrogen peroxide, H,O,; hydroxyl radical, OH-; and
superoxide radical, 02–) either during or immediately
after ischemia (Phillis, 1994). Thus, hydroxyl (OH–)
radical concentration increased significantly during
reperfusion of ischemic cat retina (Ophir et al., 1993).
The burst of activated oxygen-derived, free radical
speciesis responsiblefor pemxidationof cell membranes
resulting in tissue edema, degradation of proteins and
enzymes, and damage to DNA (Phillis, 1994).
Physiologicalactionsof NO are destroyedby 02- and
stabilized by superoxide dismutase. Superoxide dismu-
tase catalyzes the breakdown of 02– (Traystman et al.,
1991). Injection of L-NA into the vitreous of rabbits
inhibited the protective effect of superoxide dismutase
during and after ocular ischemia (Veriac et al., 1993).
The investigators speculated that NO may promote
vasodilatation of ocular vessels after ischemia, a
neuroprotectiveeffect abolished by inactivation of NO
when oxygen-derived free radicals are generated. Our
group investigatedthe effect of NOS inhibitionadminis-
tered prior to retinal ischemia on ERG a- and b-wave
recovery in cats (Ostwald et al., 1995). We found no
significantdifference in recovery between L-NAMEand
a saline group. However, these findings are difficult to
interpret due to the long-lasting depressive effects of
NOS inhibitionon ERG wave amplitudes.Both our study
and that of Veriac et al. did not examine other indices of
ischemic damage. Perhaps functional and histopatholo-
gical measurementswould be more usefulwhen studying
the impact of NOS inhibition.
The administration of antioxidants may effectively
enhance NO levels by decreasing the availabilityof free
radicals to combine with NO to form other free radical
species.The short-livedNO and the mildly reactive Oz–
combine to form a potent and long-lived oxidant,
peroxynitrite(ONOO–): 02–. + NO”-> ONOO- (Beck-
man et al., 1990;Blough & Zafiriou, 1985;Koppenolet
al., 1992). A vicious circle ensues, whereby ONOO–
breaks down to OH–, lipid peroxidation occurs, with
subsequentformationof free fatty acids, followedin turn
by further free radical formation (Beckman, 1991;
Traystman et al., 1991).
As mentionedpreviously,NO may have either toxic or
neuroprotectiveeffects in ischemia.This paradoxmay be
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explained by the redox state assumed by NO. NO may
exist under physiological conditions as the free radical
nitrogen monoxide (NO., where the . symbolizes an
unpaired electron) or the cation nitrosonium (NO+)
(Stamler et al., 1992). Nitric oxide is believed to be
neurotoxicif the redox stateof the tissuefavorsformation
of NO. and neuroprotective if the medium favors NO+
formation(Lipton et al., 1993).Neurotoxiceffectsof NO
may be mediated through ONOO– formation, whereas
the neuroprotectiveeffect of nitrosoniummay stem from
nitrosylation and deactivation of NMDA receptors,
inhibitingfurtherNMDA-mediatedneurotoxicity(Lipton
et al., 1993). Consistentwith a possible neuroprotective
effect of NO+ in the retina was the finding that sodium
nitroprusside significantly decreased NMDA-induced
currents in cultured rat retinal neurons (Ujihara et al.,
1993).
Nitric oxide: Neurotoxic or neuroprotective?
If modulation of NO concentration is to play a
therapeutic role in retinal ischemia, it is important to
determine when and how to alter its concentration, as
well as the relative activity of cNOS and iNOS. In a
preliminary study, cNOS gene expression decreased to
10% of baseline level 12–96 hr after the end of 2 hr of
retinal ischemia in rats. Expression of iNOS increased
20-fold at 12 hr after the end of ischemia (Hangai et al.,
1994).These findingsresemble those of cNOS and iNOS
expression after focal cerebral ischemia (Iadecola et al.,
1995a, b). Protection of the retina from light damage
using a NOS inhibitorhas been reported (Goureau et al.,
1993a). A recent report suggests a protective effect of
NOS inhibitionafter retinal ischemiain rats (Geyer et al.,
1995).
To examine the role of NO in c~rebral ischemia,
studies have been performed to decrease NO concentra-
tion using NOS inhibition,or to increase NO concentra-
tion by administering NO donors such as sodium
nitroprusside (Zhang & Iadecola, 1993). Whether NOS
inhibition is beneficial or harmful to the outcome of
cerebral ischemia is controversial; some studies have
shown improvement in ischemic outcome, others wor-
sening.Varyingresultsmay be due to speciesdifferences,
differing ischemia models, or differences in the agents
used to inhibit NOS, as well as the timing of NOS
inhibition relative to ischemia (Pelligrino, 1993). The
controversy may derive from differing effects of NO at
various stages of ischemic injury. This issue has been
examined in detail in transgenic mice deficient in
neuronal NOS (Huang et al., 1994). The mice demon-
stratedgastrointestinal abnormalities(resemblinghuman
pyloric stenosis) and, in males, sexually aggressive be-
havior (Huang et al., 1993;Nelson et al., 1995).In these
genetically altered mice, infarct volume following
middle cerebral artery occlusionwas lower than in non-
mutants, despite similar reductions in regional cerebral
blood flow. The “additionof L-NA to inhibit endothelial
NOS resulted in an increase in infarct size. These results
indicate that neuronal NOS worsens acute ischemic
injury, probably through delayed production of NO with
its attendant inflammatoryeffects. Release of NO in the
vasculature (by endothelial NOS) is a beneficial effect
probably due to increased blood flow to ischemic areas.
Therefore, specific inhibitorsof neuronal NOS given at
the appropriatetime points could be of potential clinical
use in a setting of cerebral ischemia.
CONCLUSIONS
Although many questions remain, a large number of
studieshave examinedthe diverserole of NO in the brain
in controlof blood flow,neurotransmission,and involve-
ment in ischemia. NO in the retina is now receiving
increased attention. NOS has been found in most of the
retina. Current evidence indicates that NO is involved in
maintaining resting tone in the uveal and retinal circu-
lations.After ischemia,NO may be involvedin the patho-
genesisof reperfusioninjury.NO is known to participate
in excitatory amino acid- and free radical-mediated
reperfusion injury after ischemia in the brain, although
data are now beginning to appear about its effects.
NO appears to play a role in the visual transduction
system. NO stimulation of soluble guanylate cyclase
stimulatescGMP production in photoreceptorsand, to a
greater extent, in bipolar cells. It is likely that NO is a
neurotransmitterwithin the retina, but its significancein
visual transductionhas not been fully elucidated. Much
remains to be learned aboutNO and NOS in the retina. It
is likely that the importance of NO in the retina will
become better clarified in the near future.
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